NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Breathomix

Breathomix

Private
LoosdrechtHealthcare & Life Scienceshttps://www.breathomix.com/

Total Funding Raised

$758,000

Company Overview

Breathomix is a medical technology company that provides a device and AI-enabled platform for respiratory health diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

breath analysisnon-invasive diagnosticselectronic noseeNoseAI-powered diagnosticsbreathomicsmedical AIearly disease detectionbreathalyzer diagnosticsprecision medicinepoint-of-care diagnosticsvolatile organic compoundsVOC analysisrespiratory disease diagnosticsoncology diagnosticsmedical devicediagnostic SaaSdigital olfaction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Breathomix Comparables

Compare Breathomix with similar companies based on industry and business-model similarity.

Breathomix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Breathomix Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Rianne de Vries

Chief Executive Officer

Executive Team

Breathomix Investors

Notable investors and investment history

Breathomix investors
InvestorRounds
Life Sciences @ Work Venture ChallengeAccelerator
LongfondsGrant
CbusineZGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Monthly visitors grew 362% MoM, reaching 3K.

  • Dec 6, 2025

    Monthly visitors grew 101% MoM.

Breathomix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Breathomix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Breathomix's valuation, stock price, and market status.

Firmographic Details

HeadquartersLoosdrecht
Employee Range2
Year Founded2018
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.